Patent details

91681 Product Name: Eltrombopag, éventuellement sous forme d'un sel ou d'un solvate (y compris sous forme d'un hydrate) pharmaceutiquement acceptable (REVOLADE®)

Basic Information

Publication number:
91681
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP019415991
Legal Status:
Expired
Application number:
91681
First applicant's nationality:
Procedural language:
French

Paediatric Extension

SPC Extension Filing Date:
02/10/2019
SPC Extension Agent Name:
OFFICE FREYLINGER S.A.
SPC Extension Status:
Granted
SPC Extension Grant Date:
17/02/2021
SPC Extension Rejection Date:

Marketing Authorization

Marketing Authorization Number:
EU/1/10/612/001-006 - Revolade-Eltrombopag
Marketing Authorization Type:
Marketing Authorization Date:
15/03/2010
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
21/04/2010
First Marketing Authorization date:
15/03/2010
Grant date:
21/06/2010
Activation date:
24/05/2021
Publication date:
21/06/2010
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
15/03/2025
SPC Extension Expiration:
15/09/2025
Rejection date:
Withdrawal date:

Owner

From:
17/12/2015
 
 

Name:
NOVARTIS AG
Address:
LICHTSTRASSE 35, 4056, BASEL, Switzerland (CH)

History of Owners

From:
17/12/2015
To:
17/12/2015

Name:
GLAXO GROUP LIMITED
Address:
980 GREAT WEST ROAD, BRENTFORD, MIDDLESEX TW8 9GS, United Kingdom (GB)

Name:
NOVARTIS PHARMA AG
Address:
LICHTSTRASSE 35, 4056, BASEL, Switzerland (CH)

From:
21/04/2010
To:
16/12/2015

Name:
GLAXOSMITHKLINE LLC
Address:
ONE FRANKLIN PLAZA, P.O.BOX 7929, PHILADELPHIA,PA 19101, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
21/04/2010
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
LIU Nannan
Address:
United States (US)

2

Name:
DUFFY Kevin, J.
Address:
United States (US)

3

Name:
PRICE Alan, T.
Address:
United States (US)

4

Name:
EPPLEY Daniel, F.
Address:
United States (US)

5

Name:
WIGGALL Kenneth
Address:
United States (US)

6

Name:
SHAW Antony, N.
Address:
United States (US)

7

Name:
VISONNEAU Sophie
Address:
United States (US)

8

Name:
ERICKSON-MILLER Connie, L.
Address:
United States (US)

9

Name:
JENKINS Julian
Address:
United Kingdom (GB)

10

Name:
LUENGO Juan, I.
Address:
United States (US)

Publication

Bulletin

1

Bulletin Heading:
SPC4
Bulletin edition number:
2019/02
Publication date:
22/02/2019
Description:
Section F : Correction of granted supplementary protection certificates – I9 publication

2

Bulletin Heading:
SPCX1
Bulletin edition number:
2019/12
Publication date:
07/11/2019
Description:
Section G : Applications for extensions for pediatric use – I1E publication

3

Bulletin Heading:
SPCX2
Bulletin edition number:
2021/04
Publication date:
08/03/2021
Description:
Section H : Granted extensions for pediatric use of supplementary protection certificates – I2E publication

4

Bulletin Heading:
SPC3
Bulletin edition number:
2021/07
Publication date:
03/06/2021
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
13/05/2024
Last Annual Fee Paid Number:
24
Last Annual Fee Paid Amount:
440 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
25/02/2021 Publication 1
02/10/2019 General Document 2
02/10/2019 General Document 3
03/01/2019 Publication 1
02/10/2019 General Document 1
02/10/2019 Application Form 4
02/10/2019 General Document 4
02/10/2019 Outgoing Correspondence 1
02/10/2019 General Document 5
02/10/2019 General Document 2
03/01/2019 Outgoing Correspondence 1
25/02/2021 Certificate 1
02/10/2019 Publication 1
25/02/2021 Outgoing Correspondence 1
02/10/2019 General Document 4
02/10/2019 General Document 3
02/10/2019 FNET_DC_FRONTPAGE 1
19/07/2016 Incoming Correspondence (Post) 2